Zentiva eyes production hub in Turkey; S. Africa hands out $667M in HIV drug contracts;

@FiercePharma: J&J won't enforce its Prezista patent in Africa, provided generics makers sell quality copies. Article | Follow @FiercePharma

> Sanofi ($SNY) generics subsidiary Zentiva, based in Prague, wants to turn Turkey into a generics hub by shifting production of most meds for export to that country. Report

> South Africa awarded $667 million in HIV drug supply contracts to domestic drugmakers, with Aspen Pharmacare and Adcock Ingram taking the largest shares. Report

> Eli Lilly's ($LLY) erectile dysfunction drug Cialis may have found another use: Improving blood flow in patients with a type of muscular dystrophy. Report

> A French appeals court upheld a €197,000 ($255,760) ruling against GlaxoSmithKline ($GSK), in the case of a patient who claimed the Parkinson's treatment Requip caused his gambling addiction. Report

> Mylan ($MYL) won FDA approval for its version of version of the Pfizer ($PFE) overactive bladder drugs Detrol. Report

Medical Device News

 @FierceMedDev: Roche Dx scores top marks for glucose meter satisfaction. More | Follow @FierceMedDev

@MarkHFierce: In 2012, medical device and Dx investment in China kicked into overdrive. Find out how, and why. Editor's Corner | Follow @MarkHFierce

 @DamianFierce: We've talked a lot about M&A targets in devices, but what about Sunshine Heart? C-Pulse could be worth $2.5B. News | Follow @DamianFierce

> Board approves Abbott split, effective Jan. 1, 2013. Report

> Bracco launches Class I recall of pre-filled syringes over stroke risk. Story

Biotech News

 @FierceBiotech: New feature: 23andMe sets stage for stronger ties with pharma. Editor's Corner | Follow @FierceBiotech

 @JohnCFierce:  So rida goes down in flames in europe as well. Merck pulls app. More | Follow @JohnCFierce

 @RyanMFierce: Monkeys lost 10% of their body weight on $AMGN's experimental antibody in 11-week study. News | Follow @RyanMFierce

> Lilly chief prods China's drug regulators on clinical development timelines. Report

> Johnson & Johnson unit wins FDA panel backing for new tuberculosis therapy. News

> Amarin scraps another Vascepa deadline as red-hot buyout rumors smolder. Story

Pharma Manufacturing News

> Bracco Diagnostics recalls angiography drug over particulates. Story

> Eli Lilly CEO endorses anti-counterfeiting campaign in China. Report

> Capsugel gets organic designation for European products. News

Vaccines News

> Virus found in dogs may fuel new vaccines. Report

> CureVac, German scientists take aim at faster flu vaccine. Article

> Danish-made TB vaccine sickens Romanian children. Item

> Selecta inks $900M immunotherapy deal with Sanofi. Story

And Finally... Philadelphia Phillies catcher Carlos "Chooch" Ruiz was suspended for taking Adderall, considered a violation of Major League Baseball's performance-enhancing drug policy. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.